US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Quantum-Si Incorporated - Class A Common Stock (NQ:QSI)

1.550 +0.120 (+8.39%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Quantum-Si Incorporated - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Tech Stocks AISP, PRSO, QSI, SCKT: $29M DHS Awards, Military Drones, Protein Sequencing Drive Catalysts
Via AB Newswire
Topics Artificial Intelligence
News headline image
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
All measurable sequencing metrics show profound improvement over Platinum Pro 
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™
Milestone continues the progress towards detection of all 20 amino acids by end of 2026 
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities
Growing Multi-City Program Continues to Increase Awareness of Proteus and Support Customer Funnel Development Ahead of Commercial Launch 
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces First Customer Samples Tested on the Proteus™ Prototype System
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Start of the Proteus™ Roadshow
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company’s Industry Leading Technology Pipeline at Investor & Analyst Day
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Reports Third Quarter 2025 Financial Results
From Quantum-Si Incorporated
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >